Katie L Davis-Anderson1, Sebastian Berger2, Emilie R Lunde-Young1, Vishal D Naik1, Heewon Seo3, Greg A Johnson3, Hanno Steen2, Jayanth Ramadoss1. 1. Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas. 2. Departments of Pathology, Harvard Medical School and Boston Children's Hospital, Boston, Massachusetts. 3. Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas.
Abstract
BACKGROUND: Fetal alcohol spectrum disorders (FASD) describe many of the well-known neurodevelopmental deficits afflicting children exposed to alcohol in utero. The effects of alcohol on the maternal-fetal interface, especially the placenta, have been less explored. We herein hypothesized that chronic binge alcohol exposure during pregnancy significantly alters the placental protein profile in a rat FASD model. METHODS: Pregnant rats were orogastrically treated daily with alcohol (4.5 g/kg, gestational day [GD] 5 to 10; 6.0 g/kg, GD 11 to 19) or 50% maltose dextrin (isocalorically matched pair-fed controls). On GD 20, placentae were collected, flash-frozen, and stored until tissues were homogenized. Protein lysates were denatured, reduced, captured on a 10-kDa spin filter, and digested. Peptides were eluted, reconstituted, and analyzed by a Q Exactive™ Hybrid Quadrupole-Orbitrap™ mass spectrometer. RESULTS: Mass spectrometry (MS) analysis identified 2,285 placental proteins based on normalized spectral counts and 2,000 proteins by intensity-based absolute quantification. Forty-five placental proteins were significantly (p < 0.05) altered by gestational alcohol exposure by both quantification approaches. These included proteins directly related to alcohol metabolism; specific isoforms of alcohol dehydrogenase and aldehyde dehydrogenase were up-regulated in the alcohol group. Ingenuity analysis identified ethanol degradation as the most significantly altered canonical pathway in placenta, and fetal/organ development as most altered function, with increased risk for metabolic, neurological, and cardiovascular diseases. Physiological roles of the significantly altered proteins were related to early pregnancy adaptations, implantation, gestational diseases, fetal organ development, neurodevelopment, and immune functions. CONCLUSIONS: We conclude that the placenta is a valuable organ not only to understand FASD etiology but it may also serve as a diagnostic tool to identify novel biomarkers for detecting the outcome of fetal alcohol exposure. Placental MS analysis can offer sophisticated insights into identifying alcohol metabolism-related enzymes and regulators of fetal development.
BACKGROUND:Fetal alcohol spectrum disorders (FASD) describe many of the well-known neurodevelopmental deficits afflicting children exposed to alcohol in utero. The effects of alcohol on the maternal-fetal interface, especially the placenta, have been less explored. We herein hypothesized that chronic binge alcohol exposure during pregnancy significantly alters the placental protein profile in a rat FASD model. METHODS: Pregnant rats were orogastrically treated daily with alcohol (4.5 g/kg, gestational day [GD] 5 to 10; 6.0 g/kg, GD 11 to 19) or 50% maltose dextrin (isocalorically matched pair-fed controls). On GD 20, placentae were collected, flash-frozen, and stored until tissues were homogenized. Protein lysates were denatured, reduced, captured on a 10-kDa spin filter, and digested. Peptides were eluted, reconstituted, and analyzed by a Q Exactive™ Hybrid Quadrupole-Orbitrap™ mass spectrometer. RESULTS: Mass spectrometry (MS) analysis identified 2,285 placental proteins based on normalized spectral counts and 2,000 proteins by intensity-based absolute quantification. Forty-five placental proteins were significantly (p < 0.05) altered by gestational alcohol exposure by both quantification approaches. These included proteins directly related to alcohol metabolism; specific isoforms of alcohol dehydrogenase and aldehyde dehydrogenase were up-regulated in the alcohol group. Ingenuity analysis identified ethanol degradation as the most significantly altered canonical pathway in placenta, and fetal/organ development as most altered function, with increased risk for metabolic, neurological, and cardiovascular diseases. Physiological roles of the significantly altered proteins were related to early pregnancy adaptations, implantation, gestational diseases, fetal organ development, neurodevelopment, and immune functions. CONCLUSIONS: We conclude that the placenta is a valuable organ not only to understand FASD etiology but it may also serve as a diagnostic tool to identify novel biomarkers for detecting the outcome of fetal alcohol exposure. Placental MS analysis can offer sophisticated insights into identifying alcohol metabolism-related enzymes and regulators of fetal development.
Authors: Catherine E Lewis; Kevin G F Thomas; Neil C Dodge; Christopher D Molteno; Ernesta M Meintjes; Joseph L Jacobson; Sandra W Jacobson Journal: Alcohol Clin Exp Res Date: 2015-04 Impact factor: 3.455
Authors: Philip A May; Amy Baete; Jaymi Russo; Amy J Elliott; Jason Blankenship; Wendy O Kalberg; David Buckley; Marita Brooks; Julie Hasken; Omar Abdul-Rahman; Margaret P Adam; Luther K Robinson; Melanie Manning; H Eugene Hoyme Journal: Pediatrics Date: 2014-11 Impact factor: 7.124
Authors: G A Johnson; F W Bazer; L A Jaeger; H Ka; J E Garlow; C Pfarrer; T E Spencer; R C Burghardt Journal: Biol Reprod Date: 2001-09 Impact factor: 4.285
Authors: Wei Zhang; Pamela A Wearsch; Yajuan Zhu; Ralf M Leonhardt; Peter Cresswell Journal: Proc Natl Acad Sci U S A Date: 2011-03-07 Impact factor: 11.205
Authors: Larry Burd; Eric Deal; Rodrigo Rios; Edward Adickes; Joshua Wynne; Marilyn G Klug Journal: Congenit Heart Dis Date: 2007 Jul-Aug Impact factor: 2.007
Authors: F Gundogan; G Elwood; L Longato; M Tong; A Feijoo; R I Carlson; J R Wands; S M de la Monte Journal: Placenta Date: 2007-12-03 Impact factor: 3.481
Authors: Bradley D Holbrook; Suzy Davies; Sandra Cano; Shikhar Shrestha; Lauren L Jantzie; William F Rayburn; Ludmila N Bakhireva; Daniel D Savage Journal: Birth Defects Res Date: 2019-03-19 Impact factor: 2.344
Authors: Jamie O Lo; Matthias C Schabel; Victoria H J Roberts; Terry K Morgan; Suzanne S Fei; Lina Gao; Karina G Ray; Katherine S Lewandowski; Natali P Newman; Jacqueline A Bohn; Kathleen A Grant; Antonio E Frias; Christopher D Kroenke Journal: Am J Obstet Gynecol Date: 2021-08-05 Impact factor: 8.661
Authors: Sze Ting Cecilia Kwan; Brandon H Presswood; Kaylee K Helfrich; Joshua W Baulch; Sandra M Mooney; Susan M Smith Journal: Biol Sex Differ Date: 2020-07-20 Impact factor: 5.027